ALT completes end-of-phase-2 meeting_with_FDA: https://www.globenewswire.com/news-release/2024/11/07/2976554/0/en/Altimmune-Announces-Successful-Completion-of-End-of-Phase-2-Meeting-with-FDA-for-Pemvidutide-in-the-Treatment-of-Obesity.html